Klinisk studie med Bactiguards endotrakealtub nu publicerad | IT-Halsa.se
it-hälsa.se,
Klinisk studie med Bactiguards endotrakealtub nu publicerad – visar signifikant reduktion av ventilator-associerad…
Klinisk studie med Bactiguards endotrakealtub nu publicerad – visar signifikant reduktion av ventilator-associerad…
The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care.
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
Published: Jan. 10, 2022 at 6:44 AM CST|Updated: 11 minutes ago STOCKHOLM, Jan.
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
Published: Jan. 10, 2022 at 7:44 AM EST|Updated: 11 minutes ago STOCKHOLM, Jan.
Published: Jan. 10, 2022 at 7:44 AM EST|Updated: 11 minutes ago STOCKHOLM, Jan.
Published: Jan. 10, 2022 at 6:44 AM CST|Updated: 10 minutes ago STOCKHOLM, Jan.
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
Published: Jan. 10, 2022 at 7:44 AM EST|Updated: 8 minutes ago STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by…
Published: Jan. 10, 2022 at 6:44 AM CST|Updated: 8 minutes ago STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
Clinical study on Bactiguard's endotracheal tube now published - shows significant reduction of ventilator-associated pneumonia…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor and his team, is now published in the well renowned…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor and his team, is now published in the well renowned…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
Published: Jan. 10, 2022 at 6:44 AM CST|Updated: moments ago STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by…
Published: Jan. 10, 2022 at 7:44 AM EST|Updated: moments ago STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- "These are very important…
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…
The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care.
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well…